Author:
Friedman Mark T.,West Kamille A.,Bizargity Peyman,Annen Kyle,Gur H. Deniz,Hilbert Timothy
Publisher
Springer International Publishing
Reference23 articles.
1. Padmanabhan A, Connelly-Smith L, Aqui N, Balogun RA, Klingel R, Meyer E, et al. Guidelines on the use of therapeutic apheresis in clinical practice—evidence-based approach from the Writing Committee of the American Society for Apheresis: the eighth special issue. J Clin Apher. 2019;34:303.
2. Hayes MM, Vedamurthy A, George G, Dweik R, Klings ES, Machado RF, et al. Pulmonary hypertension in sickle cell disease. Ann Am Thorac Soc. 2014;11(9):1488–9.
3. Adams RJ, McKie VC, Hsu L, Files B, Vichinsky E, Pegelow C, et al. Prevention of a first stroke by transfusion in children with abnormal results of transcranial Doppler ultrasonography. N Engl J Med. 1998;339:5–11.
4. Adams RJ, Brambilla D. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N Engl J Med. 2005;353:2769–78.
5. Randolph TR. Hemoglobinopathies (structural defects in hemoglobin). In: Keohane EM, Otto CN, Walenga JM, editors. Rodak’s hematology. Clinical principles and applications. 6th ed. Amsterdam: Elsevier; 2020. p. 406–8.